Skip to main content

Table 2 The crude and age standardized prevalence of MS in Tehran, Iran during 2006–2018

From: Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999–2018

Year

Female

Male

Total

Population

Count

Prevalence*

ASP (95%CI)

Population

Count

Prevalence*

ASP (95%CI)

Population

Count

Prevalence*

ASP (95%CI)

2006

5,513,872

6848

124.2

115.4 (112.6–118.2)

5,831,418

2146

36.8

33.9 (32.4–25.3)

11,345,290

8994

79.3

73.7 (72.1–75.2)

2007

5,593,267

7633

136.5

126.7 (123.8–129.6)

5,915,395

2397

40.5

37.2 (35.7–38.7)

11,508,662

10,030

87.2

80.9 (79.3–82.5)

2008

5,673,810

8447

148.9

137.9 (134.9–141.0)

6,000,577

2665

44.4

40.9 (39.3–42.5)

11,674,387

11,112

95.2

88.3 (86.6–90.0)

2009

5,755,513

9232

160.4

148.3 (145.2–151.4)

6,086,985

2930

48.1

44.3 (42.7–45.9)

11,842,498

12,162

102.7

95.1 (93.4–96.8)

2010

5,838,393

10,160

174.0

160.6 (157.4–163.8)

6,174,637

3198

51.8

47.7 (46.0–49.3)

12,013,030

13,358

111.2

102.8 (101.0–104.6)

2011

6,045,398

11,187

185.1

170.2 (167.0–173.4)

6,137,993

3513

57.2

52.4 (50.6–54.2)

12,183,391

14,700

120.7

111.2 (109.3–113.0)

2012

6,149,379

12,028

195.6

179.4 (176.1–182.7)

6,243,566

3780

60.6

55.3 (53.5–57.1)

12,392,945

15,808

127.6

117.2 (115.4–119.1)

2013

6,255,149

12,867

205.7

188.2 (184.9–191.5)

6,350,955

4083

64.3

58.7 (56.8–60.5)

12,606,104

16,950

134.5

123.3 (121.4–125.2)

2014

6,362,737

13,583

213.5

194.9 (191.5–198.2)

6,460,192

4357

67.5

61.4 (59.6–63.3)

12,822,929

17,940

139.9

128.0 (126.1–129.9)

2015

6,472,176

14,211

219.6

200.0 (196.7–203.4)

6,571,307

4591

69.9

63.6 (61.7–65.4)

13,043,483

18,802

144.2

131.6 (129.7–133.6)

2016

6,593,965

14,875

225.6

205.0 (201.7–208.4)

6,673,672

4828

72.3

65.7 (63.8–67.6)

13,267,637

19,703

148.5

135.3 (133.4–137.3)

2017

6,693,000

15,304

228.7

207.6 (204.2–210.9)

6,768,000

5037

74.4

67.5 (65.6–69.4)

13,461,000

20,341

151.1

137.5 (135.6–139.5)

2018

6,784,000

15,505

228.6

207.3 (204.0–210.7)

6,853,000

5131

74.9

67.9 (66.0–69.8)

13,636,000

20,636

151.3

137.6 (135.7–139.5)

  1. *Crude Prevalence (Per 100,000)
  2. Age Standardized Prevalence (Per 100,000)